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ABSTRACT 
Dried blood spots (DBS) are an alternative method of collecting venous blood samples that can be used to 
measure blood biomarkers. Two confounding factors, hemoglobin and hematocrit, limit the validity of 
DBS in comparison to the gold standard serum sample. The saturation of biomarkers on DBS filter paper is 
affected by the sample’s hematocrit and hemoglobin. Also hemoglobin contamination is known to 
confounder for antibody binding in assay systems. The purpose of this study was two-fold: 1) to evaluate a 
DBS punching technique designed to limit the effects of hematocrit whilst minimizing sample volume and 
2) to evaluate a novel device designed to remove hemoglobin from plasma during DBS collection 
(Seraform™). A bead-based multiplex assay of nine cardiovascular disease risk (CVD) biomarkers (C-
reactive protein, fibrinogen, L-selectin, Haptoglobin, serum amyloid protein, von Willebrand factor, 
adipsin, α2-macroglobulin, and α1-acid glycoprotein) was measured and compared using the various DBS 
treatments. Outcomes were compared using linear regression analysis examining the R2 change with 
hematocrit and hemoglobin as covariates. Significance was set at P<0.05. The “edge to edge” punching 
technique employed in this report resulted in a majority of the biomarkers having the same concentration 
in comparison to whole spot punching. The Seraform™ device can effectively remove hemoglobin from 
analysis an accurately predict the concentration of C-reactive protein, fibrinogen, and von Willebrand 
factor. The other 6 biomarkers had lower predicative potential between the Seraform and the whole DBS 
sample. The key findings of the present study demonstrate alternate methodologies for 
collecting/processing DBS samples for routine outcome measures in clinical population studies. 
 
  
 
 
 
 
  
